4.6 Article

Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease

Journal

JOURNAL OF BONE AND MINERAL RESEARCH
Volume 36, Issue 2, Pages 298-304

Publisher

WILEY
DOI: 10.1002/jbmr.4182

Keywords

FRACTURE RISK ASSESSMENT; PARATHYROID‐ RELATED DISORDERS; PTH; Vit D; FGF23

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases
  2. Eunice Kennedy Shriver National Institute of Child Health and Human Development
  3. National Heart, Lung and Blood Institute [U01-DK66143, U01-DK-66174, U01-DK-082194, U01-DK-66116]
  4. NIH [UL1TR000124, P30AG021684, K24-DK091419]
  5. NIDDK [T32-DK104687, K23-DK123378]
  6. NICHD [R01HD091185]
  7. NIH/NCATS [UL1TR00457]

Ask authors/readers for more resources

The study found racial and ethnic differences in bone markers and fractures among children with chronic kidney disease, with black and Hispanic children having lower odds of fractures compared to white children.
Studies in healthy children have shown racial-ethnic differences in bone markers and bone outcomes including fractures. At present, limited studies have evaluated the impact of race and ethnicity on bone markers and fractures within the pediatric chronic kidney disease (CKD) population. In a cohort study of 762 children between the ages of 1.5 years and 18 years, with CKD stages 1 to 4 from the CKD in children (CKiD) cohort, the relationship between racial-ethnic group and bone markers (parathyroid hormone [PTH], 25-hydroxyvitamin D [25-OHD], 1,25-dihydroxyvitamin D [1,25(OH)(2)D], and C-terminal fibroblast growth factor [FGF23]) was determined using linear mixed models. Additionally, logistic regression was used to evaluate racial-ethnic differences in prevalent fracture upon study entry. Black race was associated with 23% higher PTH levels (confidence interval [CI], 2.5% to 47.7%; p = .03), 33.1% lower 25-OHD levels (CI, -39.7% to -25.7%; p < .0001), and no difference in C-terminal FGF23 or 1,25(OH)(2)D levels when compared to whites. Hispanic ethnicity was associated with 15.9% lower C-terminal FGF23 levels (CI, -28.3% to -1.5%; p = .03) and 13.8% lower 25-OHD levels (CI, -22.2% to -4.5%; p = .005) when compared to whites. Black and Hispanic children had 74% (odds ratio [OR] 0.26; CI, 0.14 to 0.49; p = .001) and 66% (OR 0.34; CI, 0.17 to 0.65; p < .0001) lower odds of any fracture than white children at study entry, respectively. Race and ethnicity are associated with differences in bone markers and despite lower 25-OHD levels, both black and Hispanic children with CKD reported a lower prevalent fracture history than white children. The current findings in the CKD population are similar to racial-ethnic differences described in healthy children. Additional studies are needed to better understand how these differences might impact the management of pediatric CKD-MBD. (c) 2020 American Society for Bone and Mineral Research (ASBMR).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Urology & Nephrology

Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus

Rajiv Agarwal, James Burton, Maurizio Gallieni, Kamyar Kalantar-Zadeh, Gert Mayer, Carol Pollock, Jacek C. Szepietowski

Summary: Despite the limited increase in life expectancy for patients with end-stage kidney disease after the breakthrough of kidney replacement therapy, the quality of life and relief of symptoms have become increasingly important to patients. Currently, most dialysis-associated symptoms and adverse effects do not have approved treatments, and the few available treatments may add further adverse effects. This article demonstrates how understanding the pathophysiology of a particular symptom (chronic kidney disease-associated pruritus) in dialysis led to the development and regulatory approval of a treatment for that symptom. This approach can be applied to other dialysis-associated symptoms, improving the remaining years of patients' lives.

CLINICAL KIDNEY JOURNAL (2023)

Editorial Material Urology & Nephrology

Innovations in multimodal and integrated approaches in kidney care and renal transplantation

Ekamol Tantisattamo, Ramy M. Hanna, Kamyar Kalantar-Zadeh

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2023)

Review Urology & Nephrology

New and old approaches to nutritional management of acute and chronic glomerulonephritis

Ramy M. M. Hanna, Rebecca S. S. Ahdoot, Connie M. M. Rhee, Ekamol Tantisattamo, Fawaz Al Ammar, Kamyar Kalantar-Zadeh

Summary: A low protein diet is often recommended for the nutritional management of chronic kidney disease, but there is a need for more exploration of dietary recommendations for different types of renal patients. Proteinuria is a serious issue for renal disease patients, and nutritional strategies need to be explored to control proteinuria and inflammation, which is of great significance for the treatment of autoimmune kidney diseases such as glomerulonephritis.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2023)

Review Urology & Nephrology

Practicing health equity in involuntary discharges to overcome disparities in dialysis and kidney patient care

Dawn P. Edwards, Kamyar Kalantar-Zadeh, Elani Streja, Rebecca S. Ahdoot, Keith C. Norris, Donald Molony

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2023)

Review Urology & Nephrology

Changing landscape of living kidney donation and the role of telemedicine

Fawaz Al Ammary, Abimereki D. Muzaale, Ekamol Tantisattamoa, Ramy M. Hanna, Uttam G. Reddy, Suphamai Bunnapradist, Kamyar Kalantar-Zadeh

Summary: There has been a decrease in living kidney donation over the past two decades, particularly among low-income families and racial/ethnic minorities who face barriers to completing complex evaluations. Telemedicine, specifically the use of live-video visits, is seen as a potential solution to overcome these barriers and improve access to transplant centers for donor evaluation. However, providers perceive payor policy and out-of-state licensing as major obstacles to the growth of telemedicine.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2023)

Review Urology & Nephrology

Traditions and innovations in assessment of glomerular filtration rate using creatinine to cystatin C

Maria Clarissa Tio, Tariq Shafi, Xiaoqian Zhu, Kamyar Kalantar-Zadeh, Alexandre Chan, Lee Nguyen

Summary: This review focuses on the evolution of GFR estimating equations, nuances in eGFR interpretation, and the utility of eGFR in drug dosing.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2023)

Review Urology & Nephrology

Paradigm shift in lifestyle modification for solitary kidney after donor nephrectomy

Ekamol Tantisattamo, Kamyar Kalantar-Zadeh

Summary: Living donor kidney transplantation may lead to long-term complications, but dietary interventions have the potential to prevent them and improve the health outcomes of donors. Low protein and low sodium intake, as well as certain healthy dietary patterns, may help slow down the decline in kidney function. However, further research is needed to determine the optimal protein and sodium intake as well as the appropriate dietary patterns for living kidney donors.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2023)

Review Urology & Nephrology

Novel insights in classic versus relative glomerular hyperfiltration and implications on pharmacotherapy

Dana Bielopolski, Elani Streja, Tali Steinmetz, Benaya Rozen-Zvi, Kamyar Kalantar-Zadeh

Summary: Assessing and estimating glomerular filtration rate (GFR) has been a long-standing challenge in medicine and public health. Current estimation formulas do not account for variations in body surface area (BSA) or metabolic rate compared to nephron number, and fail to define renal hyperfiltration accurately.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2023)

Editorial Material Nutrition & Dietetics

Community Nutrition and Lifestyle Medicine for Kidney Health: Awareness of the Social Determinants of Health in Renal Nutrition

Kamyar Kalantar-Zadeh, Rachelle Bross, Christina Wang, Linda W. Moore

JOURNAL OF RENAL NUTRITION (2023)

Article Transplantation

Is hyponatremia a novel marker of inflammation in patients with COVID-19?

Juan Carlos Ayus, Kamyar Kalantar-Zadeh, Ekamol Tantisattamo, Connie M. Rhee, Armando L. Negri

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Review Nutrition & Dietetics

Focusing on Phosphorus Loads: From Healthy People to Chronic Kidney Disease

Mengjing Wang, Jiaying Zhang, Kamyar Kalantar-Zadeh, Jing Chen

Summary: Phosphorus is a crucial micromineral that plays a key role in cellular metabolism and tissue structure. The endocrine system coordinates the maintenance of serum phosphorus levels through the actions of hormones like FGF23, PTH, Klotho, and 1,25D. Phosphorus overload, characterized by higher than necessary phosphorus load, can be caused by diet, renal dysfunction, bone disease, dialysis insufficiency, and medications. Serum phosphorus remains the most commonly used indicator for phosphorus overload.

NUTRIENTS (2023)

Article Oncology

Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022

Kenji Ishikura, Kenji Omae, Sho Sasaki, Yugo Shibagaki, Satoko Ichioka, Yusuke Okuda, Kenichiro Koitabashi, Koichi Suyama, Takuro Mizukami, Chihiro Kondoh, Sumio Hirata, Takeshi Matsubara, Junichi Hoshino, Motoko Yanagita

Summary: Chronic kidney disease (CKD) is a disabling disorder with high incidence and prevalence in cancer survivors due to kidney damage caused by cancer and its treatment. Special attention should be given to the treatment of CKD and its complications in cancer survivors, considering their comorbidities, risk of cancer recurrence, limited physical function, and life expectancy. Shared decision-making should be adopted when selecting renal replacement therapies with sufficient information and evidence.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Nutrition & Dietetics

The Microbiome and Protein Carbamylation: Potential Targets for Protein-Restricted Diets Supplemented with Ketoanalogues in Predialysis Chronic Kidney Disease

Valentin Faerber, Katharina S. Kuhn, Liliana Garneata, Kamyar Kalantar-Zadeh, Sahir Kalim, Dominic S. Raj, Martin Westphal

Summary: In chronic kidney disease (CKD), a protein-restricted diet with essential amino acid (EAA) and their ketoanalogues (KA) supplementation can delay disease progression and improve clinical outcomes. This approach improves nitrogen balance and other metabolic disturbances, and also modulates gut dysbiosis and reduces the generation of gut-derived uremic toxins. Lowering urea levels can contribute to decreased morbidity and mortality, possibly through reducing protein carbamylation. Further studies are needed to investigate the effects on the gut microbiome, uremic toxin generation, and carbamylation markers.

NUTRIENTS (2023)

Article Medicine, General & Internal

Liver Disease Is a Risk Factor for Recurrent Hyperkalemia: A Retrospective Cohort Study

Rebecca S. Ahdoot, Jui-Ting Hsiung, Abiy Agiro, Yasmin G. Brahmbhatt, Kerry Cooper, Souhiela Fawaz, Laura Westfall, Kamyar Kalantar-Zadeh, Elani Streja

Summary: Liver disease is commonly associated with potassium imbalance, but its role as a risk factor for hyperkalemia is not well-established. This study aimed to investigate the relationship between liver disease and recurrent hyperkalemia. The results showed that patients with liver disease had a significantly higher risk of recurrent hyperkalemia within one year after the initial event.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Pharmacology & Pharmacy

Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis

Praveen K. Potukuchi, Hamid Moradi, Frank Park, Cameron Kaplan, Fridtjof Thomas, Ankur A. Dashputre, Keiichi Sumida, Miklos Z. Molnar, Abduzhappar Gaipov, Justin D. Gatwood, Connie Rhee, Elani Streja, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy

Summary: This observational study found no association between cannabis use and the risk of acute kidney injury in patients with advanced chronic kidney disease.

CANNABIS AND CANNABINOID RESEARCH (2023)

No Data Available